Insights

Strategic partnership CDI collaborates with clinical trial platforms (e.g., CliniOps) to offer end-to-end GI testing solutions, indicating opportunities to position CDI as a preferred provider for CROs and study sponsors running gastroenterology trials.

Non-invasive testing A focus on at-home breath tests for SIBO, IMO, and malabsorption positions CDI to sell scalable, patient-friendly diagnostics to GI clinics, primary care networks seeking easy-to-use screening tools.

Regulatory maturity With CLIA-certified laboratory operations and FDA-registered, ISO 13485-certified manufacturing, CDI demonstrates strong compliance credentials that can ease procurement conversations for hospital systems and decentralized testing programs.

Moderate revenue scale Current revenue in the low tens of millions and a lean employee base suggest high-margin partnerships, white-labeling, or contract testing opportunities with larger diagnostics players seeking expansion without large overhead.

Tech-enabled reach Adopted tech stack and digital marketing tools indicate readiness for expanded customer acquisition, loyalty programs, and direct-to-practice sales, making CDI a candidate for sales motions that leverage online platforms and partnerships.

Commonwealth Diagnostics International, Inc. Tech Stack

Commonwealth Diagnostics International, Inc. uses 8 technology products and services including Cloudflare, Element UI, core-js, and more. Explore Commonwealth Diagnostics International, Inc.'s tech stack below.

Cloudflare

Content Management System

Element UI

Javascript Frameworks

core-js

Javascript Libraries

Microsoft

Miscellaneous

SharpSpring Ads

Retargeting

Gravity Forms

Web Platform Extensions

Nginx

Web Servers

Essential Grid

Web Tools And Plugins

Commonwealth Diagnostics International, Inc. Email Formats	Example	Percentage
FLast@commdx.com	JDoe@commdx.com	100%

Commonwealth Diagnostics International, Inc. Email Formats

Example

Percentage

FLast@commdx.com

JDoe@commdx.com

100%

Frequently Asked Questions

What is Commonwealth Diagnostics International, Inc.'s official website and social media links?

Commonwealth Diagnostics International, Inc.'s official website is commdx.com and has social profiles on LinkedIn.

What is Commonwealth Diagnostics International, Inc.'s NAICS code?

Commonwealth Diagnostics International, Inc.'s NAICS code is 62 - Health Care and Social Assistance.

How many employees does Commonwealth Diagnostics International, Inc. have currently?

As of July 2026, Commonwealth Diagnostics International, Inc. has approximately 22 employees across 1 continents, including North America. Key team members include Chief Financial Officer: Z. A.Director, Business & Legal Affairs: A. C.Sr. Mgr. Corporate Strategy & Finance: M. M.. Explore Commonwealth Diagnostics International, Inc.'s employee directory with LeadIQ.

What industry does Commonwealth Diagnostics International, Inc. belong to?

Commonwealth Diagnostics International, Inc. operates in the Hospitals and Health Care industry.

What technology does Commonwealth Diagnostics International, Inc. use?

Commonwealth Diagnostics International, Inc.'s tech stack includes CloudflareElement UIcore-jsMicrosoftSharpSpring AdsGravity FormsNginxEssential Grid.

What is Commonwealth Diagnostics International, Inc.'s email format?

Commonwealth Diagnostics International, Inc.'s email format typically follows the pattern of FLast@commdx.com. Find more Commonwealth Diagnostics International, Inc. email formats with LeadIQ.

When was Commonwealth Diagnostics International, Inc. founded?

Commonwealth Diagnostics International, Inc. was founded in 2015.

Commonwealth Diagnostics International, Inc.

Hospitals and Health CareMassachusetts, United States11-50 Employees

Commonwealth Diagnostics International, Inc. is a Salem, Massachusetts-based company that operates a CLIA-certified laboratory and is registered with the FDA, with ISO 13485 certification for medical device manufacturing. The organization offers at-home breath tests that measure hydrogen and methane to support the diagnosis of digestive conditions such as Small Intestinal Bacterial Overgrowth (SIBO) and intestinal methanogen overgrowth (IMO), as well as various carbohydrate malabsorption disorders. The tests are designed to be straightforward and safe for patients, aiding clinicians in guiding dietary changes, supplementation, probiotics, and other interventions to address GI health outcomes. 

The company serves healthcare providers and gastroenterology-focused practices seeking non-invasive diagnostic options within the hospital and health care industry. Founded in 2015, CDI operates as a small to midsize enterprise, centered in Salem. In October 2022, CDI participated in a strategic partnership with CliniOps and My Total Health to deliver an end-to-end clinical trial solution for the gastroenterology community, reflecting a notable collaboration in its recent activity.

Insights

Similar companies to Commonwealth Diagnostics International, Inc.

Quest Diagnostics

Access Labs

Genova Diagnostics

LetsGetChecked

LabCorp